Rouquette-Jazdanian AK, et al. (2012) LAT-Independent Erk Activation via Bam32-PLC-γ1-Pak1 Complexes: GTPase-Independent Pak1 Activation. Mol Cell 48, 298-312 22981863

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

Y139-p - DAPP1 (human) ▲

Modsite: kVEEPsIyEsVRVHT SwissProt Entrez-Gene Orthologous residues DAPP1 (human): Y139‑p, DAPP1 iso2 (human): Y139‑p, DAPP1 (mouse): Y139‑p Characterization Methods used to characterize site in vivo:  immunoprecipitation, mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  leukemia, T cell leukemia Relevant cell lines - cell types - tissues:  CD4+ (T lymphocyte), Jurkat (T lymphocyte) Cellular systems studied:  cell lines Species studied:  human Upstream Regulation Potential in vivo enzymes for site:  Type Enzyme Evidence Notes KINASE Lck (human) co-immunoprecipitation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes calyculin_A CD3E (human) increase Downstream Regulation Effect of modification (function):  phosphorylation Comments:  pS141 negatively regulates pY139 and vice versa

S141-p - DAPP1 (human) ▲

Modsite: EEPsIyEsVRVHTAM SwissProt Entrez-Gene Orthologous residues DAPP1 (human): S141‑p, DAPP1 iso2 (human): S141‑p, DAPP1 (mouse): S141‑p Characterization Methods used to characterize site in vivo:  immunoprecipitation, mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  leukemia, T cell leukemia Relevant cell lines - cell types - tissues:  CD4+ (T lymphocyte), Jurkat (T lymphocyte) Cellular systems studied:  cell lines Species studied:  human Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes calyculin_A CD3E (human) increase Downstream Regulation Effect of modification (function):  enzymatic activity, induced, molecular association, regulation, phosphorylation Effect of modification (process):  signaling pathway regulation Modification regulates interactions with:  Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays PLCG1 (human) Induces co-immunoprecipitation Comments:  pS141 negatively regulates pY139 and vice versa

S199-p - PAK1 (human) ▲

Modsite: PRPEHtKsVyTRsVI SwissProt Entrez-Gene Orthologous residues PAK1 (human): S199‑p, PAK1 (mouse): S199‑p, PAK1 (rat): S198‑p Characterization Methods used to characterize site in vivo:  immunoprecipitation, mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  leukemia, T cell leukemia Relevant cell lines - cell types - tissues:  CD4+ (T lymphocyte), Jurkat (T lymphocyte) Cellular systems studied:  cell lines Species studied:  human Upstream Regulation Potential in vivo enzymes for site:  Type Enzyme Evidence Notes KINASE PAK1 (human) co-immunoprecipitation Comments:  Autophosphorylation

S204-p - PAK1 (human) ▲

Modsite: tKsVyTRsVIEPLPV SwissProt Entrez-Gene Orthologous residues PAK1 (human): S204‑p, PAK1 (mouse): S204‑p, PAK1 (rat): S203‑p Characterization Methods used to characterize site in vivo:  immunoprecipitation, mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  leukemia, T cell leukemia Relevant cell lines - cell types - tissues:  CD4+ (T lymphocyte), Jurkat (T lymphocyte) Cellular systems studied:  cell lines Species studied:  human Upstream Regulation Potential in vivo enzymes for site:  Type Enzyme Evidence Notes KINASE PAK1 (human) co-immunoprecipitation Comments:  Autophosphorylation